IL138290A0 - Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage - Google Patents

Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage

Info

Publication number
IL138290A0
IL138290A0 IL13829099A IL13829099A IL138290A0 IL 138290 A0 IL138290 A0 IL 138290A0 IL 13829099 A IL13829099 A IL 13829099A IL 13829099 A IL13829099 A IL 13829099A IL 138290 A0 IL138290 A0 IL 138290A0
Authority
IL
Israel
Prior art keywords
desmethylselegiline
burns
selegiline
treating wounds
dermatological
Prior art date
Application number
IL13829099A
Other languages
English (en)
Original Assignee
Somerset Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Somerset Pharmaceuticals Inc filed Critical Somerset Pharmaceuticals Inc
Publication of IL138290A0 publication Critical patent/IL138290A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IL13829099A 1998-03-16 1999-03-03 Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage IL138290A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7804398P 1998-03-16 1998-03-16
PCT/US1999/004588 WO1999047133A1 (en) 1998-03-16 1999-03-03 Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage

Publications (1)

Publication Number Publication Date
IL138290A0 true IL138290A0 (en) 2001-10-31

Family

ID=22141568

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13829099A IL138290A0 (en) 1998-03-16 1999-03-03 Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage
IL138290A IL138290A (en) 1998-03-16 2000-09-06 Use of selegiline or desmethylselegiline in the manufacture of medicaments for treating wounds, burns and dermatological damage

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL138290A IL138290A (en) 1998-03-16 2000-09-06 Use of selegiline or desmethylselegiline in the manufacture of medicaments for treating wounds, burns and dermatological damage

Country Status (13)

Country Link
US (3) US6461619B1 (de)
EP (1) EP1063981B1 (de)
CN (1) CN1154484C (de)
AT (1) ATE222101T1 (de)
AU (1) AU750909B2 (de)
BR (1) BR9908713A (de)
CA (1) CA2322878C (de)
DE (1) DE69902520T2 (de)
DK (1) DK1063981T3 (de)
ES (1) ES2178405T3 (de)
HK (1) HK1037980A1 (de)
IL (2) IL138290A0 (de)
WO (1) WO1999047133A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6033682A (en) 1995-01-13 2000-03-07 Somerset Pharmaceuticals, Inc. S(+) desmethylselegiline and its use in therapeutic methods and pharmaceutical compositions
DE69902520T2 (de) 1998-03-16 2003-04-10 Somerset Pharmaceuticals, Inc. Verwendung von selegilin oder desmethylselegilin zur behandlung von wunden, verbrennungen und hautschäden
AU8679801A (en) * 2000-08-28 2002-03-22 Somerset Pharmaceuticals Inc Methods and pharmaceutical compositions employing desmethylselegiline to treat neoplastic diseases or conditions
FR2813195B1 (fr) * 2000-08-29 2003-04-04 Serobiologiques Lab Sa Utilisation d'extraits de la plante cassia alata dans des produits de soin
JP2005536449A (ja) * 2001-12-18 2005-12-02 ブラシカ・ファウンデーション・ケモプロテクション・リサーチ，インコーポレイテッド グルタチオンおよび第２相解毒酵素による酸化ストレス障害の予防および治療
DE10229456A1 (de) * 2002-07-01 2004-02-05 Wank, Rudolf, Prof. Dr.med. Verwendung von Dopamin-Rezeptor-Agonisten zur Behandlung von Hautgeschwülsten und Warzen
US20050276762A1 (en) * 2004-06-15 2005-12-15 Tapas Das Topical compositions containing 5'-adenosine-diphosphate ribose
US20090075860A1 (en) * 2005-04-28 2009-03-19 Japan Science And Technology Agency Transdermal absorption enhancer
ATE415153T1 (de) * 2005-06-06 2008-12-15 Nitto Denko Corp Pharmazeutische zusammensetzung zur perkutane absorption unter verwendung von einem metalchlorid, vorzugsweise natriumchlorid, zur vorbeugung von kohäsionsschwäche
US20090324693A1 (en) * 2008-06-30 2009-12-31 Kimberly-Clark Worldwide, Inc. Delivery Product for Topical Compositions
WO2012051374A2 (en) * 2010-10-15 2012-04-19 The Procter & Gamble Company Use of monoamine oxidase inhibitors to improve epithelial biology
WO2012082950A2 (en) * 2010-12-14 2012-06-21 University Of Rochester Chimeric fibronectin matrix mimetics and uses thereof
US9539201B2 (en) 2012-04-20 2017-01-10 KAT Transdermals LLC Selegiline transdermal system
IT201800006455A1 (it) * 2018-06-19 2019-12-19 Nuovo utilizzo degli inibitori della monoammino ossidasi B

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3764144D1 (de) 1986-04-16 1990-09-13 Asta Pharma Ag Synergistische kombination von amantadin und selegilin.
EP0252290B1 (de) 1986-06-10 1992-06-03 CHIESI FARMACEUTICI S.p.A. Levodopa-methyl-ester enthaltende pharmazeutische Zusammensetzungen, ihre Herstellung und therapeutische Verwendungen
US4861800A (en) 1987-08-18 1989-08-29 Buyske Donald A Method for administering the drug deprenyl so as to minimize the danger of side effects
US4868218A (en) 1987-08-18 1989-09-19 Buyske Donald A Method of treating depression
US5446070A (en) 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
GB8807504D0 (en) 1988-03-29 1988-05-05 Sandoz Ltd Improvements in/relating to organic compounds
US4959205A (en) * 1989-03-23 1990-09-25 Collagen Corporation Composition and method for treatment of dermal inflammation
US5192550A (en) 1990-05-07 1993-03-09 Alza Corporation Dosage form for treating central nervous system disorders
US5190763A (en) 1990-05-07 1993-03-02 Alza Corporation Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
US5221536A (en) 1990-05-07 1993-06-22 Alza Corporation Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
US5057321A (en) 1990-06-13 1991-10-15 Alza Corporation Dosage form comprising drug and maltodextrin
US5128145A (en) 1990-06-13 1992-07-07 Alza Corporation Dosage form for Parkinson's disease, spasticity and muscle spasms
CA2039194C (en) 1990-08-31 1997-01-28 Norton W. Milgram Uses of l-deprenyl and compositions for same
US5783606A (en) * 1995-02-10 1998-07-21 The University Of Toronto Innovations Foundation Deprenyl compounds for treatment of glaucoma
HU209605B (en) 1991-04-15 1994-09-28 Chinoin Gyogyszer Es Vegyeszet Process for production of wather-free transdermal preparation
US5266332A (en) 1991-12-06 1993-11-30 Alza Corporation Method for administering anti-Parkinson drug
EP0593807A1 (de) 1992-10-22 1994-04-27 LTS Lohmann Therapie-Systeme GmbH & Co. KG Transdermales Pflaster zur Abgabe von basischen, flüchtigen pharmazeutischen Wirkstoffen und Verfahren zu ihrer Herstellung
US5242950A (en) 1992-04-23 1993-09-07 Somerset Pharmaceuticals, Inc. Treatment of macular degeneration
US5354885A (en) 1992-12-24 1994-10-11 Yissum Research Development Company Of The Hebrew University Of Jerusalem Process for preparing ethyl ester of L-DOPA
FR2713087B1 (fr) * 1993-11-30 1996-02-23 Saurat Jean Hilaire Utilisation de la sélégiline et ses dérivés pour la préparation d'un médicament destiné au traitement du psoriasis.
FR2728790B1 (fr) * 1994-12-29 1997-01-24 Cird Galderma Composition modulant l'apoptose comprenant du methonial ou tout facteur influencant le taux intracellulaire de methonial
CN100360123C (zh) * 1995-01-13 2008-01-09 萨默塞特药品有限公司 应用去甲司来吉兰的方法和医药组合物
CA2244253C (en) * 1996-03-15 2002-11-12 Somerset Pharmaceuticals, Inc. Method for preventing and treating peripheral neuropathy by administering selegiline
US6262111B1 (en) * 1997-05-21 2001-07-17 Sloan-Kettering Institute For Cancer Research Method for increasing the concentration of ascorbic acid in brain tissues of a subject
US20020006913A1 (en) * 1997-11-04 2002-01-17 Von Borstel Reid W. Antimutagenic compositions for treatment and prevention of photodamage to skin
DE69902520T2 (de) * 1998-03-16 2003-04-10 Somerset Pharmaceuticals, Inc. Verwendung von selegilin oder desmethylselegilin zur behandlung von wunden, verbrennungen und hautschäden

Also Published As

Publication number Publication date
IL138290A (en) 2010-05-17
US20040180009A1 (en) 2004-09-16
DK1063981T3 (da) 2002-10-14
EP1063981A1 (de) 2001-01-03
AU750909B2 (en) 2002-08-01
CA2322878C (en) 2008-05-06
BR9908713A (pt) 2000-11-21
DE69902520T2 (de) 2003-04-10
US20030021833A1 (en) 2003-01-30
WO1999047133A1 (en) 1999-09-23
ES2178405T3 (es) 2002-12-16
US6709664B2 (en) 2004-03-23
AU2979199A (en) 1999-10-11
CA2322878A1 (en) 1999-09-23
DE69902520D1 (de) 2002-09-19
US6461619B1 (en) 2002-10-08
CN1154484C (zh) 2004-06-23
HK1037980A1 (en) 2002-03-01
ATE222101T1 (de) 2002-08-15
US7147864B2 (en) 2006-12-12
EP1063981B1 (de) 2002-08-14
CN1300209A (zh) 2001-06-20

Similar Documents

Publication Publication Date Title
MY119711A (en) Method of inhibiting photoaging of skin
EP0590076A4 (en) Production of human hemoglobin in transgenic pigs
EP0801946A3 (de) Verwendung von Salicin als antiirritativer Wirkstoff in kosmetischen und topischen dermatologischen Zubereitungen
IL138290A0 (en) Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage
MY135988A (en) Additive for improving the water resistance of cosmetic or dermatological formulations
PT880350E (pt) Tratamento de esclerose multipla
DE69613840D1 (de) Orale dosierungsform und verfahren zur behandlung von schmerzzuständen in dermundhöhle
ATE186834T1 (de) Verwendung von wirksamen mengen von aktiven stoffen zur behandlung von mischhaut
DE69731477D1 (de) Mittel zur akne behandlung
GEP20063828B (en) Methods for Treating or Preventing Skin Disorders Using CD2-Binding Agents
MY164077A (en) Compositions and uses of et743 for treating cancer
DE69426267D1 (de) Äusserlisches Hautbehandlungsmittel
DE69800859D1 (de) Verwendung von Moxonidin zur Behandlung neuropathischer Schmerzen
ES2159983T3 (es) Composicion que contiene urea y sus utilizaciones en el ambito cosmetico y/o dermatologico.
ES2186914T3 (es) Utilizacion cosmetica, dermatologica y farmaceutica de un extracto de terminalia catappa.
GB2347625A (en) Agent for treating allergic or hypersensivity condition
DE69932922D1 (de) Verwendung von alkansäuren-enthaltenden zusammensetzungen zur behandlung von nagelpilz-erkrankungen
ES2187836T3 (es) Utilizacion de un extracto de terminalia catappa.
HUP9900007A2 (hu) Készítmény baromfialom kezelésére
ATE236633T1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
PT1140001E (pt) Composicao para tratamento de queimaduras
ATE358490T1 (de) Verwendung einer kombination aus einem purin und einem no-donor zur behandlung und prophylaxe sexueller funktionsstörungen
HUP0101602A2 (hu) Termékenységet javító készítmény, és annak alkalmazása
DE69626691D1 (de) Komponente b als wundheilendes mittel
UA30421A (uk) Компрес для лікування запального процесу і болю